Insider Transactions Reported by 27 Insiders of Cullinan Therapeutics, Inc.

Symbol
CGEM on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Cullinan Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ansbert Gadicke Director $102,717,212 22 Jun 2022
UBS Oncology Impact Fund L.P. 10%+ Owner $95,297,419 16 Sep 2021
Lynx1 Capital Management LP 10%+ Owner $75,297,881 +$13,322,539 +21% 28 Oct 2025
Morana Jovan-Embiricos 10%+ Owner $56,397,201 24 Jun 2022
Vision Scs F2 10%+ Owner $55,775,322 02 Aug 2022
F2 Bioscience I 2017 Ltd 10%+ Owner $55,209,813 21 Jun 2022
Nadim Ahmed President and CEO, Director $5,654,919 -$517,990 -8.4% 24 Feb 2026
Patrick Baeuerle Chief Scientific Officer $5,201,228 17 Feb 2023
Corrine Savill Chief Business Officer $3,014,785 18 Feb 2026
Jennifer Michaelson Chief Scientific Officer $2,678,833 -$575,917 -18% 05 Mar 2026
Thomas Ebeling Director $2,426,489 10 Jun 2024
Jeffrey Alan Jones Chief Medical Officer $2,314,736 -$178,948 -7.2% 24 Feb 2026
Jeffrey Trigilio Chief Financial Officer $2,166,809 22 Feb 2024
Jacquelyn L. Sumer Chief Legal Officer $1,853,447 -$136,724 -6.9% 24 Feb 2026
Mary Kay Fenton Chief Financial Officer $1,721,295 -$59,901 -3.4% 20 Feb 2026
Leigh Zawel Chief Scientific Officer, Small Molecules $869,521 11 Feb 2022
BVF PARTNERS L P/IL 10%+ Owner $799,446 19 Jan 2023
Keane Raymond T. Chief Legal Officer $300,585 11 Feb 2022
Nate Nguyen Interim PAO and PFO $216,408 29 Mar 2024
Mary Thistle Director 08 Aug 2024
Stephen W. Webster Director 12 Jun 2025
David D. Meek Director 12 Jun 2025
Anthony Rosenberg Director 12 Jun 2025
David P. Ryan Director 12 Jun 2025
Anne-Marie Martin Director 12 Jun 2025
Andrew R. Allen Director 07 Aug 2025
Mittie Doyle Director 07 Aug 2025

Recent Insider Transactions by Companies or Individuals for Cullinan Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Jennifer Michaelson CGEM Common Stock Sale -4.47% $125,440 $15.68 -8,000 170,844 05 Mar 2026 Direct
Jennifer Michaelson CGEM Common Stock Options Exercise 2.29% 4,000 178,844 05 Mar 2026 Direct
Jennifer Michaelson CGEM Stock Option (Right to Buy) Options Exercise -3.2% -4,000 120,987 05 Mar 2026 Direct
Jennifer Michaelson CGEM Common Stock Sale -1.01% $25,169 $14.14 -1,780 174,844 25 Feb 2026 Direct
Jennifer Michaelson CGEM Common Stock Sale -2% $52,106 $14.47 -3,601 176,624 24 Feb 2026 Direct
Nadim Ahmed CGEM Common Stock Sale -3.34% $195,562 $14.47 -13,515 390,803 24 Feb 2026 Direct
Jeffrey Alan Jones CGEM Common Stock Sale -2.78% $66,302 $14.47 -4,582 159,968 24 Feb 2026 Direct
Jacquelyn L. Sumer CGEM Common Stock Sale -2.73% $52,106 $14.47 -3,601 128,089 24 Feb 2026 Direct
Jennifer Michaelson CGEM Common Stock Sale -0.96% $24,510 $13.99 -1,752 180,225 23 Feb 2026 Direct
Jeffrey Alan Jones CGEM Common Stock Sale -2.94% $67,855 $13.62 -4,982 164,550 20 Feb 2026 Direct
Jennifer Michaelson CGEM Common Stock Options Exercise 4.4% 8,000 189,977 20 Feb 2026 Direct
Jennifer Michaelson CGEM Common Stock Sale -6.06% $165,366 $14.08 -11,742 181,977 20 Feb 2026 Direct
Jennifer Michaelson CGEM Stock Option (Right to Buy) Options Exercise -6.02% -8,000 124,987 20 Feb 2026 Direct
Jacquelyn L. Sumer CGEM Common Stock Sale -2.76% $50,966 $13.62 -3,742 131,690 20 Feb 2026 Direct
Nadim Ahmed CGEM Common Stock Sale -3.89% $223,109 $13.62 -16,381 404,318 20 Feb 2026 Direct
Mary Kay Fenton CGEM Common Stock Sale -3.36% $59,901 $13.62 -4,398 126,380 20 Feb 2026 Direct
Jacquelyn L. Sumer CGEM Stock Option (Right to Buy) Award 230,000 230,000 18 Feb 2026 Direct
Jeffrey Alan Jones CGEM Stock Option (Right to Buy) Award 300,000 300,000 18 Feb 2026 Direct
Nadim Ahmed CGEM Stock Option (Right to Buy) Award 828,000 828,000 18 Feb 2026 Direct
Corrine Savill CGEM Stock Option (Right to Buy) Award 175,000 175,000 18 Feb 2026 Direct
Mary Kay Fenton CGEM Common Stock Award 110.8% 68,750 130,778 18 Feb 2026 Direct
Mary Kay Fenton CGEM Stock Option (Right to Buy) Award 137,500 137,500 18 Feb 2026 Direct
Jennifer Michaelson CGEM Common Stock Award 44.8% 57,500 185,719 18 Feb 2026 Direct
Jennifer Michaelson CGEM Stock Option (Right to Buy) Award 115,000 115,000 18 Feb 2026 Direct
Jennifer Michaelson CGEM Common Stock Sale -0.32% $5,004 $12.03 -416 128,219 12 Feb 2026 Direct
Jennifer Michaelson CGEM Common Stock Sale -3.02% $49,200 $12.30 -4,000 128,635 22 Jan 2026 Direct
Mary Kay Fenton CGEM Common Stock Award 0.04% 27 62,028 31 Dec 2025 Direct
Nadim Ahmed CGEM Common Stock Sale -2.3% $99,319 $10.01 -9,922 420,699 23 Dec 2025 Direct
Jennifer Michaelson CGEM Common Stock Sale -1% $13,463 $10.01 -1,345 132,635 19 Dec 2025 Direct
Jacquelyn L. Sumer CGEM Common Stock Sale -2.51% $33,652 $9.67 -3,480 135,432 18 Dec 2025 Direct
Jeffrey Alan Jones CGEM Common Stock Sale -2.66% $44,791 $9.67 -4,632 169,532 18 Dec 2025 Direct
Jennifer Michaelson CGEM Common Stock Sale -2.12% $28,024 $9.67 -2,898 133,980 18 Dec 2025 Direct
Jennifer Michaelson CGEM Common Stock Sale -0.72% $11,840 $11.90 -995 136,878 15 Dec 2025 Direct
Jennifer Michaelson CGEM Common Stock Sale -1.53% $26,592 $12.38 -2,148 137,873 12 Dec 2025 Direct
Jennifer Michaelson CGEM Common Stock Sale -2.82% $49,200 $12.30 -4,000 138,004 24 Nov 2025 Direct
Lynx1 Capital Management LP CGEM Common stock, $0.0001 par value per share Purchase 1.88% $1,391,686 $8.40 165,667 8,963,500 28 Oct 2025 See footnote
Lynx1 Capital Management LP CGEM Common Stock Purchase 0.37% $252,565 $7.84 32,217 8,797,833 17 Oct 2025 See footnote
Lynx1 Capital Management LP CGEM Common Stock Purchase 1.74% $1,328,250 $8.86 150,000 8,765,616 16 Oct 2025 See footnote
Lynx1 Capital Management LP CGEM Common Stock Purchase 0.6% $409,049 $7.94 51,500 8,615,616 15 Oct 2025 See footnote
Lynx1 Capital Management LP CGEM Common stock, $0.0001 par value per share ("Common Stock") Purchase 0.18% $114,048 $7.59 15,032 8,564,116 14 Oct 2025 See footnote
Lynx1 Capital Management LP CGEM Common Stock Purchase 3.35% $2,041,385 $7.36 277,298 8,549,084 10 Oct 2025 See footnote
Lynx1 Capital Management LP CGEM Common Stock Purchase 8.19% $4,191,859 $6.70 626,043 8,271,786 09 Oct 2025 See footnote
Lynx1 Capital Management LP CGEM Common stock, $0.0001 par value per share ("Common Stock") Purchase 7.85% $3,593,698 $6.46 556,300 7,645,743 08 Oct 2025 See footnote
Mittie Doyle CGEM Stock Option (Right to Buy) Award 79,456 79,456 07 Aug 2025 Direct
Andrew R. Allen CGEM Stock Option (Right to Buy) Award 79,456 79,456 07 Aug 2025 Direct
David P. Ryan CGEM Stock Option (Right to Buy) Award 38,513 38,513 12 Jun 2025 Direct
Anthony Rosenberg CGEM Stock Option (Right to Buy) Award 38,513 38,513 12 Jun 2025 Direct
Stephen W. Webster CGEM Stock Option (Right to Buy) Award 38,513 38,513 12 Jun 2025 Direct
David D. Meek CGEM Stock Option (Right to Buy) Award 38,513 38,513 12 Jun 2025 Direct
Anne-Marie Martin CGEM Stock Option (Right to Buy) Award 38,513 38,513 12 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.